Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

Novel mRNA-based vaccines have been proven to be powerful tools in combating the global pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) efficiently protecting individuals from COVID-19 across a broad age range. Still, it remains largely unknown how renal insufficiency and immuno...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Invest
Hoofdauteurs: Sattler, Arne, Schrezenmeier, Eva, Weber, Ulrike A., Potekhin, Alexander, Bachmann, Friederike, Straub-Hohenbleicher, Henriette, Budde, Klemens, Storz, Elena, Proß, Vanessa, Bergmann, Yasmin, Thole, Linda M.L., Tizian, Caroline, Hölsken, Oliver, Diefenbach, Andreas, Schrezenmeier, Hubert, Jahrsdörfer, Bernd, Zemojtel, Tomasz, Jechow, Katharina, Conrad, Christian, Lukassen, Sören, Stauch, Diana, Lachmann, Nils, Choi, Mira, Halleck, Fabian, Kotsch, Katja
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Clinical Investigation 2021
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8279581/
https://ncbi.nlm.nih.gov/pubmed/34101623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI150175
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items